FDA AdComm Plans to Review Investigational Cell Therapy Deramiocel for DMD Cardiomyopathy

Capricor Therapeutics reported that it remains on track for PDUFA target action date of August 31, 2025 and noted that advisory committee meeting is to be held in advance.:

Source: Neurology Read More